04/01/2019

IMIBIC CALL FOR EXPRESSIONS OF INTEREST. POST-DOCTORAL RESEARCHERS: Miguel Servet contracts 2019

This hosting has expired


  • OFFER DEADLINE
    07/02/2019 00:00 - Europe/Brussels
  • EU RESEARCH FRAMEWORK PROGRAMME
    Not funded by an EU programme
  • LOCATION
    Spain, Córdoba
  • ORGANISATION/COMPANY
    Fundación para la Investigación Biomédica de Córdoba (FIBICO)
  • DEPARTMENT
    IMIBIC (Maimonides Biomedical Research Institute)

Reference: AES-MS-2019

Aim of the call:

We are looking for excellent candidates to apply for:

Contract type: Miguel Servet and Miguel Servet II

Position details: 5 years of postdoctoral contract, 40.500 € gross salary per year + 40.000 € for other costs.

Funding Agency: National Institute of Health Carlos III (ISCIII)

Call: Strategic Action in Health 2019 (Acción Estratégica en Salud).

Further information: http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/fd-convocatorias-ayudas-accion-estrategica-salud/2019/AES_2019.pdf

Eligibility criteria - Miguel Servet:

Candidates must fulfil at least one of the following requisites:

a) Have obtained their PhD between 1st of January 2008 and 31st of December 2014.

b) Have completed their Sara Borrell contract or are in their third year of Sara Borrell contract.

c) Have completed their Río Hortega contract, or are in their second year of Río Hortega contract AND have obtained their PhD.

Eligibility criteria - Miguel Servet Type II:

The candidates must have obtained Miguel Servet contract in the call AES2014 or previous calls and have their contract active at the time of applying for Miguel Servet Type II.

 

Applicants for both Miguel Servet and Miguel Servet Type II should carefully check their CV against the specific eligibility conditions of the call:

http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/fd-convocatorias-ayudas-accion-estrategica-salud/2019/AES_2019.pdf

 

Selection Process: The process will consist of eligibility check an evaluation of merits of all CVs received (number and quality of publications, participation in research projects, mobility, and other merits). The best positioned candidates may be called for a personal interview in order to evaluate more precisely their skills.

 

How to Apply: Send your CV to: gestion.proyectos@imibic.org and state clearly in the subject field of the email: a) the reference “AES-MS-2019” and b) the name of the research group or name of the PI of your interest.

The IMIBIC Research Groups are listed here

Deadline for expressions of interest: 7th of February of 2019.

 

Description of IMIBIC

The Maimonides Biomedical Research Institute of Cordoba, IMIBIC, located in Cordoba, southern Spain, is a partnership between the University of Cordoba and the Reina Sofia University Hospital. IMIBIC offers a multidisciplinary environment focused on results-oriented research and based on precision medicine and excellence in science. IMIBIC is accredited with the Excellence distinction from the Spanish National Institute of Health Carlos III and has the HR Excellence in Research Award of the European Commission.

The Institute is structured in research groups that cooperate in the implementation of 5 core scientific programmes: Active aging and Frailty; Nutrition and endocrine and metabolic diseases; Infectious and immunological diseases and organ transplantation; Cancer; and Chronic and Inflammatory Diseases. Our major goal is to promote biomedical innovation as a powerful engine for economic and social development. To this end, the Institute offers an active environment in which to conduct high-level scientific research. Regular seminars and research events offer the opportunity to meet with national and international speakers covering a diverse range of topics in biomedicine.

IMIBIC is a young and fast growing research institution; since 2015 it operates in the brand new IMIBIC building for basic and translational research which is strategically located within the University Health Sciences Campus, next to the Reina Sofia University Hospital. It hosts a wide variety of core facilities for researchers, including the Biomedical Research Support Units with brand new equipment and laboratories to support the technical needs of the IMIBIC community, as well as a Clinical Research Unit to support clinical trial studies. IMIBIC currently hosts over 600 researchers, of which nearly 400 combine their research activities with patient care.